News & Investors

Capital increase

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.


This website does not constitute an offer to sell or a solicitation of an offer to purchase any securities of Epigenomics AG in the United States of America (“USA”) or in any other jurisdiction in which such offer or solicitation is not authorized or to any person to whom it is unlawful to make such offer or solicitation. Users of this website are requested to inform themselves about and to observe any such restrictions. The information set forth on this website must not be distributed in the USA, to “U.S. persons” as defined under the U.S. Securities Act of 1933, as amended (the “Securities Act”), or to publications with a general circulation in the USA. Each violation of such limitations may constitute a violation of applicable securities laws of the USA.
The shares of Epigenomics AG (the “Shares”) have not been registered under the Securities Act and may not be offered or sold in the USA unless registered under the Securities Act or pursuant to an exemption from such registration. There will be no public offering of the Shares in the USA and the Shares will not be registered under the Securities Act.

By clicking on the “I agree” button below, you warrant that (a) you are located in, or a resident of, Germany, (b) if you are located in, or a resident of, the United Kingdom, you are a Relevant Person and (c) you are not located in, or a resident of, the USA (and are not otherwise a “U.S. person” as defined under Regulation S). You further undertake that you will not transmit or otherwise send any information contained in this web site to any person located in, or a resident of, the USA.

I agree

I do not agree